SUPPORTING STATEMENT B for
Process Evaluation of the NIH Roadmap Epigenomics Program (NIDA)
May 2011
Social & Scientific Systems, Inc. (SSS) with funding from the National Institute on Drug Abuse (NIDA)
Genevieve deAlmeida-Morris, Ph.D., MPH.,
Office of Science Policy and Communications
NSC - Neuro Science Center, 5229
6001 Executive Blvd
Rockville, MD 20852
Phone: 301-594-6802
Fax: 301-480-2485
E-mail: dealmeig@nida.nih.gov
B. COLLECTIONS OF INFORMATION EMPLOYING STATISTICAL METHODS 3
1. Respondent Universe and Sampling Methods 3
2. Procedures for the Collection of Information 3
3. Methods to Maximize Response Rates and Deal With Nonresponse 5
4. Test of Procedures or Methods to be Undertaken 5
5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data 5
ATTACHMENTS for Supporting Statement B:
Attachment B-1: Introductory Email from NIH Program Staff
Attachment B-2: Initial Contact Email for Survey Invitation to Participant
Attachment B-3: Survey Reminder Email Notices
Process Evaluation of the NIH Roadmap Epigenomics Program
SUPPORTING STATEMENT
Part B
B. COLLECTIONS OF INFORMATION EMPLOYING STATISTICAL METHODS
Analysis for this study will employ descriptive, non-inferential methods of analysis. The following information is provided.
The respondent universe includes the entire population of Principal Investigators (PI) [grantees] from the 53 NIH grants of the Roadmap Epigenomics Program. There is no sampling plan.
For the PI survey of the NIH Roadmap Epigenomics Program’s process evaluation, we expect a response rate of 100% since this is a required activity for every grantee (PI). Specialized sampling procedures are not required.
To initiate the PI survey, NIH Program staff will send an introductory email to PIs. This email will inform them about the PI survey and that they (the PIs) will be contacted by email by Social and Scientific Systems (SSS) the evaluation Contractor for this study and who will be conducting the survey. (See participant-contact schedule shown in Table B.2-1 below with referenced attachments.) PIs will then receive from SSS an email request (including a URL link to the survey with a study ID along with survey directions) for their participation in the survey, with collateral materials explaining the survey’s purpose and use of the information collection, the non-personal nature of the information including protection by blinding, and analyses to be conducted in the aggregate only. Only participants who have been provided with an ID number and password will have access to the online research instrument. All PIs will be asked to complete the survey within two (2) weeks. Quality control measures will include data logging checks prior to and during the study. Participants will receive up to two e-mail reminders (a week apart beginning 2 weeks after the survey invitation is sent).
Table B.2-1 Participant Recruitment Contacts |
||
Contact Item |
Timing (from time of first contact) |
Attachment Number |
Introductory email from NIH Program staff |
Day 1 |
B-1 |
Follow-up email from SSS survey liaison with survey URL, log-in ID, password |
Days 1-2 |
B-2 |
First reminder email asking for completion within 5 days |
Day 14 |
B-3 |
Second reminder email asking for completion within 3 days |
Day 21 |
B-3 |
Phone contact for any PIs who haven’t completed survey |
Day 28-29 |
|
Very little nonresponse, if any, is expected because the proposed process evaluation is a requirement for every grantee receiving funding under the Roadmap Epigenomics Program, and because this universe is a small number of respondents (53). Re-contact for their response will be highly effective.
To maximize response rates and to ensure that each grantee will complete the questionnaire as expeditiously as possible, the survey will be introduced to the Principal Investigators by email contact from the NIH Program staff, as described above. After PIs receive the email with survey directions and the URL for the web survey and a period of 2 weeks has elapsed, two subsequent reminders will be emailed a week apart, if needed, with the goal of achieving a 100% response rate.
Participants will complete the information collection questionnaire for the process evaluation. All analyses will be descriptive. Frequency analyses will be conducted. The survey instrument will be pretested to ensure that the content flow, mechanics, and automation are satisfactory, and will be revised if needed. The pretest data will be downloaded and examined to ensure the appropriate output.
The Evaluation Project Officer is Dr. Genevieve deAlmeida-Morris from NIDA. The Project Officer, the two NIH Evaluation Leads from NIDDK and NIEHS, and at least three NIH Science Program staff, and the Contractor will review the final report, including data analysis. The Project Officer will direct the project. Table B.5-1 below shows the individuals who will be consulted on conduct of the project, data collection, and data analysis, or who will collect and analyze data.
Table B.5 - 1 Individuals’ Roles |
||
Name and Title |
Affiliation and Phone Number |
Statistical Role |
Susan Griffey, DrPH, BSN Evaluation Project Director |
Social & Scientific Systems, tel: 301.628.0340 |
Data collection and analysis |
Genevieve deAlmeida-Morris, Ph.D, MPH Planning & Evaluation Officer |
NIDA, tel: 301.594.6802 |
Advising on data collection and analysis |
Kathryn Paez, PhD, MBA, RN Senior Evaluator |
Social & Scientific Systems, tel: 301.628.0428 |
Data collection and analysis |
David Roessner, PhD, MS Academic Advisor and Evaluation Expert |
Social & Scientific Systems, tel: 928.713.0942 |
Consulting on data collection and analysis |
Bernard Weissman, PhD Epigenetics Expert |
Consultant for Social & Scientific Systems, tel: 919.966.7533 |
Consulting on data collection and analysis |
In addition, Contractor research and web technical assistants will also assist with data collection.
Feb.
7,
2010:
EP PI Survey-OMB Supporting Statement B
| File Type | application/msword |
| Author | tberry |
| Last Modified By | dealmeig |
| File Modified | 2011-05-13 |
| File Created | 2011-02-07 |